Showing results (501-510 of 544) with videos related to
Sort By:
Pageof 55
Pigment Cell Research|October 21, 2000
Stem cell factor and/or endothelin-3 dependent immortal melanoblast and melanocyte populations derived from mouse neural crest cellsY Kawa, M Ito, H Ono, et al.AIDS (London, England)|August 10, 2000
Lipopolysaccharide-induced HIV-1 expression in transgenic mice is mediated by tumor necrosis factor-alpha and interleukin-1, but not by interferon-gamma nor interleukin-6J Tanaka, H Ozaki, J Yasuda, et al.European Journal of Pharmacology|March 12, 1997
Renal effect of YM435, a new dopamine D1 receptor agonist, in anesthetized dogsT Yatsu, Y Arai, K Takizawa, et al.Avian Diseases|February 9, 2012
Bovine rotavirus in turkeys with enteritisK M Asano, F Gregori, S P Souza, et al.Biochemical and Biophysical Research Communications|February 17, 2001
TAG-1-deficient mice have marked elevation of adenosine A1 receptors in the hippocampusF Fukamauchi, O Aihara, Y J Wang, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 11, 1999
The human T cell leukemia virus type I-tax gene is responsible for the development of both inflammatory polyarthropathy resembling rheumatoid arthritis and noninflammatory ankylotic arthropathy in transgenic miceK Habu, J Nakayama-Yamada, M Asano, et al.Thescientificworldjournal|December 19, 2013
A multigene approach for comparing genealogy of Betacoronavirus from cattle and horsesIracema N Barros, Sheila O S Silva, Francisco S Nogueira Neto, et al.Journal of Diabetes and Its Complications|September 1, 1996
Long-term effects of eicosapentaenoic acid on diabetic peripheral neuropathy and serum lipids in patients with type II diabetes mellitusY Okuda, M Mizutani, M Ogawa, et al.Journal of Medicinal Chemistry|October 10, 1998
A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 3. Discovering bioisosteres of the imidazo[1,2-a] pyridine moietyY Abe, H Kayakiri, S Satoh, et al.Journal of Medicinal Chemistry|November 7, 1998
A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 4. Discovery of novel frameworks mimicking the active conformationY Abe, H Kayakiri, S Satoh, et al.Pageof 55